Joelle Lufkin
Chief Development Officer
- VP Clinical Development at Flexion Therapeutics, led the program for Zilretta® from IND through to NDA approval, directing Clinical Operations, Data Management, Biostatistics and Medical Writing
- On Flexion’s Executive Team, instrumental in the development of the organization from 8 to 300+ employees
- Master of Science in Public Health with a concentration in Biostatistics and Epidemiology
